Edition:
United States

Profile: Abbott India Ltd (ABOT.NS)

ABOT.NS on National Stock Exchange of India

4,544.95INR
23 Feb 2017
Change (% chg)

Rs18.80 (+0.42%)
Prev Close
Rs4,526.15
Open
Rs4,548.00
Day's High
Rs4,548.00
Day's Low
Rs4,500.00
Volume
157
Avg. Vol
2,411
52-wk High
Rs5,244.00
52-wk Low
Rs4,353.70

Abbott India Limited is a healthcare company engaged in pharmaceuticals business. The Company has a portfolio of science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. Its business operations are divided into four business divisions: Women's Health & Gastrointestine, Gastroenterology and Hepatic Care; Specialty Care; GenNext & Vaccines, and Consumer Care. Women's Health & Gastrointestine, Gastroenterology and Hepatic Care division has a mix of global and local brands present in the pregnancy, constipation and liver diseases segments. The Specialty Care division consists of a range of products in the treatment of central nervous system and metabolic disorders. The GenNext division focuses on several therapy areas, including pain management, vitamins and pregnancy. Its vaccines include Enteroshield (typhoid vaccine) and Rotasure (rotavirus diarrhea vaccine). The Consumer Care division is present in the over the counter antacid segment.

Company Address

Abbott India Ltd

3-4 Corporate Park
Sion-Trombay Road, Chembur
MUMBAI     400063
P: +9122.28717400
F: +9122.28717499

Company Web Links